BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19863574)

  • 1. A comparison of prognostic classification systems for differentiated thyroid carcinoma.
    Verburg FA; Mäder U; Kruitwagen CL; Luster M; Reiners C
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):830-8. PubMed ID: 19863574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
    Lang B; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example.
    Brierley JD; Panzarella T; Tsang RW; Gospodarowicz MK; O'Sullivan B
    Cancer; 1997 Jun; 79(12):2414-23. PubMed ID: 9191532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
    Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
    Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
    Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
    J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
    Lee J; Soh EY
    Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Need for a revised staging consensus in medullary thyroid carcinoma.
    Boostrom SY; Grant CS; Thompson GB; Farley DR; Richards ML; Hoskin TL; Hay ID
    Arch Surg; 2009 Jul; 144(7):663-9. PubMed ID: 19620547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplifying the TNM system for clinical use in differentiated thyroid cancer.
    Onitilo AA; Engel JM; Lundgren CI; Hall P; Thalib L; Doi SA
    J Clin Oncol; 2009 Apr; 27(11):1872-8. PubMed ID: 19273697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Endocr Relat Cancer; 2007 Mar; 14(1):29-42. PubMed ID: 17395973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
    Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
    Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma.
    Verburg FA; Mäder U; Luster M; Reiners C
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):291-7. PubMed ID: 19067727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan expression in differentiated thyroid carcinoma.
    Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM
    J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
    Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the new TNM classification (1997) improve prognostic stratification in gastric cancer submitted to R0 surgery?
    Mendes de Almeida JC; Limbert M; Mendes de Almeida JM
    Eur J Surg Oncol; 1999 Jun; 25(3):280-3. PubMed ID: 10336808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Chinese classification system compared with TNM staging in prognosis of patients with primary hepatic carcinoma after resection.
    Sheng JM; Zhao WH; Wu FS; Ma ZM; Feng YZ; Zhou XR; Teng LS
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):561-4. PubMed ID: 16286262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.